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TECHNICAL NOTE
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Normal human pregnancy is characterized by increased an-
giotensinogen [I], plasma renin activity (PRA), plasma renin
concentration (PRC), plasma angiotensin 11 levels, and plasma
aldosterone levels [2—4]. In the hypertensive pregnant women,
plasma angiotensin II levels are variously reported as being
higher [51 or lower [4] than they are in normal pregnancy. In
the late course of hypertensive pregnancies, PRA and PRC lev-
els are relatively low [4, 61, although higher than those found
in nonpregnant normotensive women. The cause for such find-
ings in hypertensive pregnancies remains uncertain, and the
role of the renin-producing system within the maternal kidney
has not been directly investigated.
Using a specific antirenin antiserum, we previously showed
that in patients with various glomerular and vascular renal dis-
eases, the number of renin-containing cells was increased when
compared to normal kidney biopsy samples [71. We now ex-
tend our study to hypertensive pregnant women who have ei-
ther preeclampsia or isolated high blood pressure (HBP) or pre-
vious renal disease. The study shows that, in comparison with
nonpregnant normotensive women, all these patients have
fewer renin-containing cells upon postpartum renal biopsy ex-
amination.
Methods: Patients. Sixty renal needle biopsy samples from
women presenting with HBP during their pregnancy were stud-
ied retrospectively. The samples were taken 6 to 8 days after
delivery. HBP was defined as diastolic pressure 90 mm Hg.
The patients were divided into three groups.
Group 1. The preeclamptic group included 19 women (mean
age, 25 years) presenting with HBP, proteinuria  1 g per day,
and uricemia 340 moles/liter appearing during the last 3
months of pregnancy. Seven had the nephrotic syndrome at the
time of biopsy. All but 3 women were primigravidae.
Group 2. The group of isolated HBP ofpregnancy involved
29 patients (mean age, 28 years). Twenty-two of these patients
had HBP that developed in the last trimester, five patients had
HBP that appeared in the first 6 months of pregnancy, and two
patients had recurrent HBP in the course of successive preg-
nancies.
Of the 48 renal biopsy samples from these two groups, 34
displayed typical aspects of "pregnancy-induced nephrop-
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athy" (PIN) [81. The immunomorphologic glomerular lesions of
typical PIN consist of endothelial swelling, double contour ap-
pearance of the capillary loops, and glomerular deposits of fi-
brinogen-related antigen and immunoglobulins (most fre-
quently 1gM). The 14 other samples, all from the second group,
showed no glomerular changes by light and immunofluores-
cence microscopy, but arteriosclerosis and arteriolar hyali-
nosis were found in 12 patients.
Group 3. Twelve women had previous renal disease (mean
age, 28 years), of whom 7 had permanent essential hyper-
tension, 4 had segmental focal glomeruloscierosis, and one had
diabetic diffuse glomerulosclerosis. Nine of these patients also
showed the glomerular lesions of PIN, which were super-
imposed on the primary renal lesions from which they could
easily be separated.
All patients received a normal sodium diet and antihyperten-
sive drugs, excluding salt-wasting diuretics. Aldactone alone
was given in four patients. Fifty-six women took the following
antihypertensive drugs: beta-blockers (acebutolol, proprano-
lol) alone in 10 patients and with dihydralazine and/or cloni-
dine in 10 other patients; the 36 remaining women took
a-methyldopa alone or with dihydralazine and clonidine. The
duration of therapy was variable, lasting from several days to
the entire length of the pregnancy in some cases. Thirty pa-
tients were maintained on antihypertensive medications up un-
til the time of renal biopsy.
Controls. The control group consisted of 20 normal kidney
biopsy samples, examined by both light microscopy and im-
munofluorescence, from nonpregnant normotensive women
(mean age, 26 years). All these women had minimal urinary ab-
normalities, and they had received no antihypertensive drugs.
Analysis of variance failed to show any significant difference
among the mean age of all groups (F [3, 59 dj] = 1.88; NS).
Immunohistochemical procedure. An antihuman renin an-
tiserum was developed in rabbits by repeated injection of pure
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Table 1. Number of JGA-positive and JGA-negative renal biopsy
samplesa
Group 2: Group 3:
Group 1: Isolated Previous
Controls Preeclampsia HEP renal disease
JGA-negative 8 15 24 5
JGA-positive 12 4 5 7
Total number 20 19 29 12
Abbreviations: HBP, high blood pressure; JGA-positive, renal biopsy
samples containing at least one fluorescent juxtaglomerular apparatus;
JGA-negative, renal biopsy samples with no fluorescent juxtaglomeru-
lar apparatus.
a Heterogeneity between groups: x2 (2, 3 df) = 14.01; F C 0.01.
human rcnin as previously described [9]. This antiserum was
specific for primate renin and did not cross-react with other
proteases such as pepsin and cathepsin D, At a dilution of
1:80,000, it inhibited the enzymatic activity of 25 microgold-
blatt units. It cross-reacted with inactive renin from human kid-
ney, amniotic fluid, and human placenta. Radioimmunoassays
showed the immunologic identity between nonactivated and
acid-activated renin.
Renal tissue specimens were fixed in Bouin's solution and
embedded in paraffin. Three-micron-thick sections were depar-
affinized, passed through successive alcohol baths, and washed
in phosphate saline buffer.
The indirect immunofluorescence technique was carried out
as follows. Sections were incubated with unlabeled rabbit re-
nm antiserum at 1:50 dilution for 30 mm. After washing, tissue
sections were incubated with fluoresceinated goat antirabbit
immunoglobulin for 30 minutes (Hyland Laboratories). The
slides were mounted in buffered gelatin and examined under
ultraviolet light with a Leitz Ortoplan Ortomat microscope.
Only biopsy samples containing at least 10 glomeruli were in-
cluded in this study. Analysis of variance did not show any sig-
nificant differences between the means of the number of
glomeruli on each group's renal biopsy samples (F 13, 59 41] =
0.51; NS).
Statistical analysis. Among hypertensive pregnant women,
numerous renal biopsy samples did not show any fluorescent
juxtaglomerular apparatus (JGA), so that the distribution of the
number of fluorescent JGAs was not Gaussian. Only 3 renal bi-
opsy samples contained more than one fluorescent JGA, ren-
dering rank tests useless. For these reasons, we classified as
JGA-positive the samples containing at least one fluorescent
JGA and as JGA-negative the samples with no fluorescent
JGA. Heterogeneity between groups was tested by the chi-
square test. Proportions of JGA-positive samples in each group
of patients were compared with those observed in the control
group by the chi-square test.
Results. The proportion of JGA-positive biopsy samples was
lower in all the hypertensive pregnant groups than in controls
(Table 1). Twenty-seven percent of biopsy samples from all
hypertensive pregnant women were JGA-positive. Interlobular
arteries were all negative. In the control group of nonhyper-
tensive nonpregnant women, 60% of renal biopsy samples were
JGA-positive. Some of the JGA-positive renal samples con-
tained more than three renin-containing cells, and rare positive
cells were found in interlobular arteries. In the preeclamptic
group and the clinically isolated gravid HBP group, the number
of JGA-positive renal biopsies was lower than in the control
group (x2 = 6.10, P < 0.02, and x2 = 9.55, P < 0.01, respec-
tively). No difference existed between controls and patients
with previous renal disease. Among pregnant women, the ef-
fect of beta-blocking agents seemed to be irrelevant (69% JGA-
negative among treated patients vs. 75% JGA-negative among
untreated patients who did not receive beta-blockers) (x2 =
0.23, NS). Moreover, the percentage of JGA-negative renal
samples in pregnant women presenting with a nephrotic syn-
drome (67%) was not statistically different from the percentage
of pregnant women without a nephrotic syndrome (74%) (x2 =
0.24, NS).
Discussion. Our results indicate that renin-containing cells in
the kidney of hypertensive pregnant women are rare or ab-
sent. Before discussing the implications of this interesting find-
ing, we must present some of the drawbacks of our study. For
obvious reasons, it was not possible to biopsy hypertensive
pregnant women until early in the puerperium. Although we
recognize that there are many striking physiologic changes in
the early postpartum period, we still feel that the marked dif-
ference in the number of renin-containing cells between our pa-
tient and control groups is noteworthy and deserving of expla-
nation. Theoretically, our control group should have consisted
of women biopsied after normal pregnancies, but for ethical
reasons we chose a control group of young women biopsied be-
cause of minor urinary abnormalities who proved to have es-
sentially normal kidneys. We believe that this is a valid if not
ideal control group as these women were comparable in age
and in hormonal secretory capacity to our patients. Because
our study is a retrospective one, we are not able to report PRA
as this was rarely measured in our patients.
The use of beta-blockers in many of our patients may seem
at first glance an important influencing factor. However, we
have previously shown that there is no correlation between the
use of beta-blockers and the number of renin-containing cells
found in kidney biopsy samples by our immunohistochemical
method [7]. The same is true of our current study. The only rel-
evant correlation in our previous study [7] was that of an in-
creased number of renin-containing cells in biopsy samples
from patients with the nephrotic syndrome and in those with
various primary glomerulonephritides. In contrast to our initial
study, the glomerular lesions of PIN were not associated with
an increased number of renin-containing cells.
In our hypertensive pregnant patients with the nephrotic syn-
drome, we were surprised to find far fewer renin-containing
cells than in normal kidneys. We speculate that the hyperten-
sive pregnant state may in some way counteract the effect of
the nephrotic syndrome, based alone on the number of renin-
containing cells seen in the samples. These factors are un-
known but may include plasma volume differences between
hypertensive and normal pregnant or nonpregnant women [10]
and differences in angiotensin 11 levels [11] or in extra-renal
sources of renin [6, 11—14].
The only group of hypertensive pregnant women found to
have numbers of renin-containing cells approaching those seen
in control biopsy samples was the group with previous glomer-
ular disease. This may imply that previous glomerular lesions
modify the usual effects of pregnancy on the kidney.
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